04028694000027

Organization name

TRB Chemedica AG

SRN

DE-MF-000006919

Manufacturer status

Active

3 warnings recorded — scroll inside the panel to see all entries.

• CW007

  EUDAMED did not publish a description for this code.
• CW999

  Contra-Indications: Individual hypersensitivity to any constituent of the product. Precautions: Do not touch the tip of the opened container and do not touch the surface of the eye with the tip of the opened container. Otherwise, the container should be discarded immediately after use. Reclose the container after use. As VISLUBE® does not contain preservatives any solution not used within 12 hours after opening must be discarded. Otherwise, the sterility is no longer guaranteed and this may be associated with a risk of infection. Do not use VISLUBE® if the container is damaged. If discomfort persists while using VISLUBE® consult a physician.
• CW135

  EUDAMED did not publish a description for this code.

Primary placement in Germany; available across 4 countries total.

Trade name

not provided

UDI-DI code

04028694000027

Basic UDI-DI

4028694VISLUBE9X

Reference / catalog number

04028694000027

Issuing entity

GS1

Risk category

Class IIb

Applicable legislation

MDR [Regulation (EU) 2017/745 on medical devices]

Status

On the market

Quantity

20

Additional product description

VISLUBE® Sodium hyaluronate from fermentation 0.18 %. Transparent solution of natural, highly purified sodium hyaluronate. Devoid of animal proteins. Sterile, free from preservatives.

Additional information URL

https://www.trbchemedica.de/

Clinical sizes

No clinical sizes registered for this device.

• Q02030301OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification